Abstract
Apolipoproteins of the C group are peptides of small molecular weights, present in chylomicrons, VLDL, IDL, and HDL. These polypeptides have common characteristics: they are regulators (activators or inhibitors) of the lipid metabolism of lipoproteins, particularly the catabolism of triglyceride-rich lipoproteins [1]. The distribution of the different Apo C in lipoprotein classes varies between normal subjects and hypertriglyceridemics and in relation to fasting and the type of diet.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Schaefer EJ, Eisenberg S, Levy RI (1978) Lipoprotein apoprotein metabolism. J Lipid Res 19: 667–687
Kashyap ML, Srivastava LS, Chen CY, Perisutti G, Campbell M, Lutmer RF, Glueck CJ (1977) Radioimmunoassay of human apolipoprotein C-II. A study in normal and hypertriglyceridemia subjects. J Clin Invest 60: 171–180
Schonfeld G, George PK, Miller J, Reilly P, Witztum J (1979) Apolipoprotein C-II and C-III levels in hyperlipoproteinemia. Metabolism 28: 1001–1010
Kashyap ML, Srivastava LS, Hynd BA, Gartside PS, Perisutti G (1981) Quantitation of human apolipoprotein C-III and its subspecies by radioimmunoassay and analytical isoelectric focusing: abnormal plasma triglyceride-rich lipoprotein apolipoprotein C-III subspecies concentrations in hypertriglyceridemia. J Lipid Res 22: 800–810
Barr SI, Kottke BA, Mao SJT (1985) Postprandial distribution of apolipoproteins C-II and C-III in normal subjects and patients with mild hypertriglyceridemia: comparison of meals containing corn oil and medium-chain triglyceride oil. Metabolism 34: 983–992
Polz E, Kotite L, Havel RJ, Kane JP, Sata T (1980) Human apolipoprotein C-I: concentration in blood serum and lipoproteins. Biochem Med 24: 229–237
Curry MD, McConathy WJ, Fesmire JD, Alaupovic P (1980) Quantitative determination of human apolipoprotein C-III by electroimmunoassay. Biochim Biophys Acta 617: 503–513
Barr SI, Kottke B A, Chang JY, Mao SJT (1981) Immunochemistry of human plasma apolipoprotein C-II as studied by radioimmunoassay. Biochim Biophys Acta 663: 491–505
Curry MD, McConathy WJ, Fesmire JD, Alaupovic P (1981) Quantitative determination of apolipoproteins C-I and C-II in human plasma by separate electroimmunoassays. Clin Chem 27: 543–548
Carlson LA, Holmquist L (1982) Concentrations of apolipoproteins B, C-I, C-II, C-III and E in sera from normal men and their relation to serum lipoprotein levels. Clin Chim Acta 124: 163–178
Bukberg PR, Le N-A, Ginsberg HN, Gibson JC, Goldman LC, Brown WV (1983) Direct measurement of apolipoprotein C-III specific activity in 125I-labeled very low density lipoproteins using immunoaffinity chromatography. J Lipid Res 24: 1251–1260
Gustafson S, Ostlund-Lindqvist, Vessby B (1984) A rapid radioimmunoassay of human apolipoproteins C-II and C-III. Scand J Clin Lab Invest 44: 291–297
Weisweiler P, Schwandt P (1984) Determination of human apolipoproteins C-II and C-III by laser nephelometry. Fresenius Z Anal Chem 317: 708–709
Bury J, Rosseneu M (1985) Enzyme linked immunosorbent assay for human apolipoprotein C-III. J Clin Chem Clin Biochem 23: 63–68
Bury J, Michiels G, Rosseneu M (1986) Human apolipoprotein C-II quantitation by sandwich enzyme-linked immunosorbent assay. J Clin Chem Clin Biochem 24: 457–463
Riesen WF, Sturzenegger E (1986) Enzyme-linked immunosorbent assay for apolipoprotein C-I. J Clin Chem Clin Biochem 24: 723–727
Malmendier CL, Lontie J-F, Grutman GA, Delcroix C (1986) Metabolism of apolipoprotein CI, in normolipoproteinemic human subjects. Atherosclerosis 62:167–172
Malmendier CL, Lontie J-F, Grutman GA, Delcroix C (1988) Metabolism of apolipoprotein C-III in normolipemic human subjects. Atherosclerosis 69: 51–59
Kashyap ML, Srivastava LS, Hynd BA, Perisutti G, Brady DW, Gartside P, Glueck CJ (1978) The role of high density lipoprotein apolipoprotein C-II in triglyceride metabolism. Lipids 13: 933–942
Huff MW, Nestel PJ (1982) Metabolism of apolipoproteins C-H, C-nij, C-III2 and VLDL-B in human subjects consuming high carbohydrate diets. Metabolism 31: 493–498
Huff MW, Fidge NH, Nestel PJ, Billington T, Watson B (1981) Metabolism of C-apolipoproteins: kinetics of C-II, C-III1 and C-III2, and VLDL-apolipoprotein B in normal and hyperlipoproteinemic subjects. J Lipid Res 22: 1235–1246
Berman M, Hall M III, Levy RI, Eisenberg S, Bilheimer DW, Phair RD, Goebel RH (1978) Metabolism of ApoB and ApoC lipoproteins in man: kinetic studies in normal and hyperlipoproteinemic subjects. J Lipid Res 19: 38–56
Malmendier CL, Lontie J-F, Grutman G, Delcroix C (1987) Metabolism of apolipoprotein C: kinetic studies in human subjects: a critical review. In: Malmendier CL, Alaupovic P (eds) Lipoproteins and atherosclerosis. Plenum, New York, pp 95–103
Berman M (1982) Kinetic analysis and modeling: theory and applications to lipoproteins. In: Berman M, Grundy SM, Howard BV (eds) Lipoprotein kinetics and modeling. Academic, New York, pp 3–36
Bukberg PR, Le N-A, Ginsberg HN, Gibson JC, Rubinstein A, Brown WV (1985) Evidence for non-equilibrating pools of apolipoprotein C-III in plasma lipoproteins. J Lipid Res 26:1047–1057
Massey JB, Hickson D, She HS, Sparrow JT, Via DP, Gotto AM Jr, Pownall HJ (1984) Measurement and prediction rates of spontaneous transfer of phospholipids between plasma lipoproteins. Biochim Biophys Acta 794: 274–280
Tall AR (1986) Plasma lipid transfer proteins. J Lipid Res 27: 361–367
Albers JJ, Tollefson JH, Chen C-H, Steinmetz A (1984) Isolation and characterization of human plasma lipid transfer proteins. Arteriosclerosis 4: 49–58
Dolphin PJ (1985) Lipoprotein metabolism and the role of apolipoproteins as metabolic programmers. Can J Biochem Cell Biol 63: 850–869
Tam SP, Breckenridge WC (1983) Apolipoprotein and lipid distribution between vesicles and HDL-like particles formed during lipolysis of human very low density lipoproteins by perfused rat heart. J Lipid Res 24: 1343–1357
Schaefer EJ, Wetzel MG, Bengtsson G, Scow RO, Brewer HB Jr, Olivecrona T (1982) Transfer of human lymph chylomicron constituents to other lipoprotein density fractions during in vitro lipolysis. J Lipid Res 23: 1259–1273
Vainio P, Virtanen JA, Kinnunen PKJ, Voyta JC, Smith LC, Gotto AM Jr, Sparrow JT, Pattus F, Verger R (1983) Action of lipoprotein lipase on phospholipid monolayers. Activation by apolipoprotein C-II. Biochemistry 22: 2270–2275
Shirai K, Fitzharris TJ, Shinomiya M, Muntz HG, Harmony JAK, Jackson RL, Quinn DM (1983) Lipoprotein lipase-catalysed hydrolysis of phosphatidylcholine of guinea pig very low density lipoproteins and discoidal complexes of phospholipid and apolipoprotein: effect of apolipoprotein C-II on the catalytic mechanism. J Lipid Res 24: 721–730
Windier EET, Preyer S, Greten H (1986) Influence of lysophosphatidyl-choline on the C-apolipoprotein content of rat and human triglyceride-rich lipoproteins during triglyceride hydrolysis. J Clin Invest 78: 658–665
Scott J, Knott TJ, Shaw DJ, Brook JD (1985) Localization of genes encoding apolipoproteins C-I, C-II, and E to the pl3-cen region of human chromosome 19. Hum Genet 71: 144–146
Law SW, Gray G, Brewer HB Jr, Sakaguchi AY, Naylor SL (1984) Human apolipoprotein A-I and C-III genes reside in the p11-q13 region of chromosome 11. Biochem Biophys Res Commun 118: 934–942
Dumon M-F, Clerc M (1986) Preliminary report on a case of apolipoproteins C-I and C-II deficiency. Clin Chim Acta 157: 239–248
Norum RA, Lakier JB, Goldstein S, Angel A, Goldberg RB, Block WD, Noffze DK, Dolphin PJ, Edelglass J, Bogorad DD, Alaupovic P (1982) Familial deficiency of apolipoproteins A-I and C-III and precocious coronary-artery disease. N Engl J Med 306: 1513–1519
Puchois P, Alaupovic P, Fruchart JC (1985) Mise au point sur les classifications des lipoprotéines plasmatiques. Ann Biol Clin (Paris) 43: 831–840
Alaupovic P, Tavella M, Fesmire J (1987) Separation and identification of Apo-B-containing lipoprotein particles in normolipidemic subjects and patients with hyperlipoproteinemias. In: Malmendier CL, Alaupovic P (eds) Lipoproteins and atherosclerosis. Plenum, New York, pp7–14
Carlson LA, Ballantyne D (1976) Changing relative proportions of apolipoproteins C-II and C-III of very low density lipoproteins in hypertriglyceridemia. Atherosclerosis 23: 563–568
Erkelens DW, Mocking JAJ (1982) The C-II/C-III ratio of transferable apolipoprotein in primary and secondary hypertriglyceridemia. Clin Chim Acta 121: 56–65
Attman PO, Gustafson A, Alaupovic P, Knight C, Wang CS, Bass H (1980) Abnormalities of plasma, lipoprotein system in patients with chronic renal failure. Circulation 62: 118
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1989 Springer-Verlag Berlin Heidelberg
About this paper
Cite this paper
Malmendier, C.L., Lontie, JF. (1989). Turnover Studies of Apolipoproteins C: A First Critical Appraisal. In: Klör, H.U. (eds) Lipoprotein Subfractions Omega-3 Fatty Acids. Recent Developments in Lipid and Lipoprotein Research. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-83447-9_6
Download citation
DOI: https://doi.org/10.1007/978-3-642-83447-9_6
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-540-19146-9
Online ISBN: 978-3-642-83447-9
eBook Packages: Springer Book Archive